Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test, page-25

"How can the results in the data of one patient not be explainable by chance alone??"

I don't know I'm not a medical expert. Also, I assuming there's no medical expert at the ASX to scrutinise and interpret technical medical announcements, so rely on the company to do so IAW:

"It is the entity, and only the entity, that can and must form a view as to whether the information it knows, and the rest of the market does not, is market sensitive and therefore needs to be disclosed under Listing Rule 3.1."

Do a search for the word "sensitive" on the link I provided above.

Other than that you'd probably need to contact the company.